DrugPatentWatch Database Preview
CEPHALON Company Profile
» See Plans and Pricing
What is the competitive landscape for CEPHALON, and what generic alternatives to CEPHALON drugs are available?
CEPHALON has eight approved drugs.
There are fifteen US patents protecting CEPHALON drugs.
There are two hundred and thirty-seven patent family members on CEPHALON drugs in thirty-five countries and fourteen supplementary protection certificates in five countries.
Summary for CEPHALON
International Patents: | 237 |
US Patents: | 15 |
Tradenames: | 8 |
Ingredients: | 6 |
NDAs: | 8 |
Patent Litigation for CEPHALON: | See patent lawsuits for CEPHALON |
PTAB Cases with CEPHALON as patent owner: | See PTAB cases with CEPHALON as patent owner |
Drugs and US Patents for CEPHALON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cephalon | FENTORA | fentanyl citrate | TABLET;BUCCAL, SUBLINGUAL | 021947-004 | Sep 25, 2006 | RX | Yes | No | 8,092,832 | Start Trial | Y | Start Trial | |||
Cephalon | GABITRIL | tiagabine hydrochloride | TABLET;ORAL | 020646-006 | Nov 29, 2005 | DISCN | No | No | Start Trial | Start Trial | |||||
Cephalon | NUVIGIL | armodafinil | TABLET;ORAL | 021875-004 | Jun 15, 2007 | AB | RX | Yes | Yes | 7,132,570*PED | Start Trial | Y | Start Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CEPHALON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Cephalon | PROVIGIL | modafinil | TABLET;ORAL | 020717-001 | Dec 24, 1998 | 4,177,290 | Start Trial |
Cephalon | GABITRIL | tiagabine hydrochloride | TABLET;ORAL | 020646-002 | Sep 30, 1997 | 5,354,760 | Start Trial |
Cephalon | NUVIGIL | armodafinil | TABLET;ORAL | 021875-001 | Jun 15, 2007 | RE37516*PED | Start Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for CEPHALON drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Injection | 1 mg/mL | ➤ Subscribe | 2015-08-11 |
➤ Subscribe | Injection | 90 mg/mL, 0.5 mL and 2 mL in single-dose vials | ➤ Subscribe | 2014-06-19 |
➤ Subscribe | Tablets | 2 mg and 4 mg | ➤ Subscribe | 2005-02-01 |
➤ Subscribe | Tablets | 50 mg, 150 mg and 250 mg | ➤ Subscribe | 2009-07-24 |
➤ Subscribe | Lozenges | 0.2 mg | ➤ Subscribe | 2004-10-29 |
➤ Subscribe | Lozenges | 0.6 mg | ➤ Subscribe | 2004-12-20 |
➤ Subscribe | Injection | 25 mg/vial and 100 mg/vial | ➤ Subscribe | 2013-06-04 |
➤ Subscribe | Buccal Tablets | 0.1 mg, 0.2 mg, 0.3 mg, 0.4 mg, 0.6 mg and 0.8 mg | ➤ Subscribe | 2007-11-13 |
➤ Subscribe | Tablets | 12 mg and 16 mg | ➤ Subscribe | 2014-01-24 |
➤ Subscribe | Tablets | 100 mg and 200 mg | ➤ Subscribe | 2009-09-11 |
➤ Subscribe | Lozenges | 0.4 mg | ➤ Subscribe | 2004-10-06 |
➤ Subscribe | Lozenges | 0.8 mg, 1.2 mg and 1.6 mg | ➤ Subscribe | 2004-11-22 |
International Patents for CEPHALON Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Australia | 2004311879 | Start Trial |
Spain | 2359979 | Start Trial |
Australia | 2006204817 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for CEPHALON Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1635783 | 122014000024 | Germany | Start Trial | PRODUCT NAME: FENTANYL IN ALLEN DEM SCHUTZ DES GRUNDPATENTS UNTERLIEGENDEN FORMEN; REGISTRATION NO/DATE: EU/1/10/644/001-004 20100831 |
0836511 | 122006000022 | Germany | Start Trial | PRODUCT NAME: TRANSDERMAL IONTOPHORETISCH VERABREICHTES FENTANYL-HYDROCHLORID; REGISTRATION NO/DATE: EU/1/05/326/001 20060126 |
1769785 | C300521 | Netherlands | Start Trial | PRODUCT NAME: FENTANYL; REG NO/DATE: EU/2/11/127/001 20111006 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.